nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—Muscle spasticity—Riluzole—amyotrophic lateral sclerosis	0.0649	0.0876	CcSEcCtD
Alprazolam—Major depression—Riluzole—amyotrophic lateral sclerosis	0.0326	0.044	CcSEcCtD
Alprazolam—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.0176	0.0238	CcSEcCtD
Alprazolam—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0167	0.0225	CcSEcCtD
Alprazolam—Hostility—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0214	CcSEcCtD
Alprazolam—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0202	CcSEcCtD
Alprazolam—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0195	CcSEcCtD
Alprazolam—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0172	CcSEcCtD
Alprazolam—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0169	CcSEcCtD
Alprazolam—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0166	CcSEcCtD
Alprazolam—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0164	CcSEcCtD
Alprazolam—Mania—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0163	CcSEcCtD
Alprazolam—Stupor—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0159	CcSEcCtD
Alprazolam—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00979	0.0132	CcSEcCtD
Alprazolam—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00928	0.0125	CcSEcCtD
Alprazolam—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00928	0.0125	CcSEcCtD
Alprazolam—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00894	0.0121	CcSEcCtD
Alprazolam—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00868	0.0117	CcSEcCtD
Alprazolam—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00848	0.0114	CcSEcCtD
Alprazolam—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00848	0.0114	CcSEcCtD
Alprazolam—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00824	0.0111	CcSEcCtD
Alprazolam—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00762	0.0103	CcSEcCtD
Alprazolam—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00754	0.0102	CcSEcCtD
Alprazolam—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00747	0.0101	CcSEcCtD
Alprazolam—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00729	0.00984	CcSEcCtD
Alprazolam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00718	0.0689	CbGeAlD
Alprazolam—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.00717	1	CrCbGaD
Alprazolam—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00687	0.00928	CcSEcCtD
Alprazolam—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00678	0.00916	CcSEcCtD
Alprazolam—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00678	0.00916	CcSEcCtD
Alprazolam—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0067	0.00904	CcSEcCtD
Alprazolam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00656	0.063	CbGeAlD
Alprazolam—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00637	0.0086	CcSEcCtD
Alprazolam—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00637	0.0086	CcSEcCtD
Alprazolam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00634	0.0609	CbGeAlD
Alprazolam—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00632	0.00853	CcSEcCtD
Alprazolam—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00627	0.00847	CcSEcCtD
Alprazolam—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00606	0.00818	CcSEcCtD
Alprazolam—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00604	0.00815	CcSEcCtD
Alprazolam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00599	0.00809	CcSEcCtD
Alprazolam—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00794	CcSEcCtD
Alprazolam—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00777	CcSEcCtD
Alprazolam—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00759	CcSEcCtD
Alprazolam—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00551	0.00743	CcSEcCtD
Alprazolam—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00551	0.00743	CcSEcCtD
Alprazolam—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00713	CcSEcCtD
Alprazolam—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00695	CcSEcCtD
Alprazolam—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00687	CcSEcCtD
Alprazolam—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00679	CcSEcCtD
Alprazolam—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00677	CcSEcCtD
Alprazolam—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00498	0.00673	CcSEcCtD
Alprazolam—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00663	CcSEcCtD
Alprazolam—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00663	CcSEcCtD
Alprazolam—Depression—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00661	CcSEcCtD
Alprazolam—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00646	CcSEcCtD
Alprazolam—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00635	CcSEcCtD
Alprazolam—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00627	CcSEcCtD
Alprazolam—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00625	CcSEcCtD
Alprazolam—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00595	CcSEcCtD
Alprazolam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00592	CcSEcCtD
Alprazolam—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00592	CcSEcCtD
Alprazolam—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00588	CcSEcCtD
Alprazolam—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00434	0.00586	CcSEcCtD
Alprazolam—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00585	CcSEcCtD
Alprazolam—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00583	CcSEcCtD
Alprazolam—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00563	CcSEcCtD
Alprazolam—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00556	CcSEcCtD
Alprazolam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00412	0.0395	CbGeAlD
Alprazolam—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00552	CcSEcCtD
Alprazolam—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.004	0.0054	CcSEcCtD
Alprazolam—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00536	CcSEcCtD
Alprazolam—Chills—Riluzole—amyotrophic lateral sclerosis	0.00396	0.00534	CcSEcCtD
Alprazolam—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00386	0.00521	CcSEcCtD
Alprazolam—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00518	CcSEcCtD
Alprazolam—Tension—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00508	CcSEcCtD
Alprazolam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00376	0.0361	CbGeAlD
Alprazolam—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00503	CcSEcCtD
Alprazolam—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00501	CcSEcCtD
Alprazolam—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00498	CcSEcCtD
Alprazolam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00364	0.0349	CbGeAlD
Alprazolam—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00485	CcSEcCtD
Alprazolam—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00481	CcSEcCtD
Alprazolam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00476	CcSEcCtD
Alprazolam—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00473	CcSEcCtD
Alprazolam—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00467	CcSEcCtD
Alprazolam—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00465	CcSEcCtD
Alprazolam—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00465	CcSEcCtD
Alprazolam—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00458	CcSEcCtD
Alprazolam—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00455	CcSEcCtD
Alprazolam—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00449	CcSEcCtD
Alprazolam—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00441	CcSEcCtD
Alprazolam—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00441	CcSEcCtD
Alprazolam—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00441	CcSEcCtD
Alprazolam—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00439	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00438	CcSEcCtD
Alprazolam—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00436	CcSEcCtD
Alprazolam—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00431	CcSEcCtD
Alprazolam—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00426	CcSEcCtD
Alprazolam—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00423	CcSEcCtD
Alprazolam—Infection—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0042	CcSEcCtD
Alprazolam—Shock—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00416	CcSEcCtD
Alprazolam—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00415	CcSEcCtD
Alprazolam—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00413	CcSEcCtD
Alprazolam—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00411	CcSEcCtD
Alprazolam—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00409	CcSEcCtD
Alprazolam—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00403	CcSEcCtD
Alprazolam—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00395	CcSEcCtD
Alprazolam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00287	0.0276	CbGeAlD
Alprazolam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00287	0.0276	CbGeAlD
Alprazolam—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00385	CcSEcCtD
Alprazolam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00284	0.0273	CbGeAlD
Alprazolam—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00382	CcSEcCtD
Alprazolam—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0038	CcSEcCtD
Alprazolam—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00377	CcSEcCtD
Alprazolam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00376	CcSEcCtD
Alprazolam—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00372	CcSEcCtD
Alprazolam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00274	0.0263	CbGeAlD
Alprazolam—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00367	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00365	CcSEcCtD
Alprazolam—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00364	CcSEcCtD
Alprazolam—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00362	CcSEcCtD
Alprazolam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00265	0.0254	CbGeAlD
Alprazolam—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00348	CcSEcCtD
Alprazolam—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00346	CcSEcCtD
Alprazolam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00256	0.0246	CbGeAlD
Alprazolam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00256	0.0246	CbGeAlD
Alprazolam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00255	0.0245	CbGeAlD
Alprazolam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00253	0.0243	CbGeAlD
Alprazolam—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00336	CcSEcCtD
Alprazolam—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00334	CcSEcCtD
Alprazolam—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00334	CcSEcCtD
Alprazolam—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00311	CcSEcCtD
Alprazolam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00226	0.0217	CbGeAlD
Alprazolam—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00303	CcSEcCtD
Alprazolam—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00299	CcSEcCtD
Alprazolam—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.0022	0.0212	CbGeAlD
Alprazolam—GABRA5—brain—amyotrophic lateral sclerosis	0.00217	0.0209	CbGeAlD
Alprazolam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00216	0.0207	CbGeAlD
Alprazolam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00216	0.0207	CbGeAlD
Alprazolam—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00289	CcSEcCtD
Alprazolam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00208	0.0199	CbGeAlD
Alprazolam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00208	0.0199	CbGeAlD
Alprazolam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00207	0.0028	CcSEcCtD
Alprazolam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00203	0.0195	CbGeAlD
Alprazolam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00203	0.0195	CbGeAlD
Alprazolam—GABRA3—brain—amyotrophic lateral sclerosis	0.00202	0.0194	CbGeAlD
Alprazolam—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00269	CcSEcCtD
Alprazolam—Rash—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00267	CcSEcCtD
Alprazolam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00266	CcSEcCtD
Alprazolam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00197	0.0189	CbGeAlD
Alprazolam—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00197	0.0189	CbGeAlD
Alprazolam—Headache—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00265	CcSEcCtD
Alprazolam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.0019	0.0183	CbGeAlD
Alprazolam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.0019	0.0182	CbGeAlD
Alprazolam—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00251	CcSEcCtD
Alprazolam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00185	0.0178	CbGeAlD
Alprazolam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00183	0.0176	CbGeAlD
Alprazolam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00179	0.0172	CbGeAlD
Alprazolam—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00166	0.0159	CbGeAlD
Alprazolam—GABRB2—brain—amyotrophic lateral sclerosis	0.00165	0.0158	CbGeAlD
Alprazolam—GABRG2—brain—amyotrophic lateral sclerosis	0.00165	0.0158	CbGeAlD
Alprazolam—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00159	0.0153	CbGeAlD
Alprazolam—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00156	0.015	CbGeAlD
Alprazolam—GABRB2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00154	0.0104	CbGpPWpGaD
Alprazolam—GABRA2—brain—amyotrophic lateral sclerosis	0.00151	0.0145	CbGeAlD
Alprazolam—GABRA5—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.0015	0.0101	CbGpPWpGaD
Alprazolam—GABRA3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00147	0.00996	CbGpPWpGaD
Alprazolam—GABRA1—brain—amyotrophic lateral sclerosis	0.00146	0.014	CbGeAlD
Alprazolam—GABRA2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00144	0.00979	CbGpPWpGaD
Alprazolam—GABRB3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00144	0.00973	CbGpPWpGaD
Alprazolam—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00141	0.00955	CbGpPWpGaD
Alprazolam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0014	0.00945	CbGpPWpGaD
Alprazolam—GABRB3—brain—amyotrophic lateral sclerosis	0.00127	0.0122	CbGeAlD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00125	0.00848	CbGpPWpGaD
Alprazolam—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00123	0.00835	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00122	0.00824	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00119	0.00809	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00117	0.00795	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00117	0.0079	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00116	0.00783	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00115	0.00776	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00112	0.00761	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0011	0.00747	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00108	0.00734	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00108	0.00732	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00108	0.00729	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00106	0.00716	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.00105	0.00713	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00102	0.00692	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.001	0.00678	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000992	0.00672	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000974	0.0066	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000957	0.00648	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000951	0.00644	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000941	0.00638	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000934	0.00633	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000924	0.00626	CbGpPWpGaD
Alprazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00092	0.00623	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000915	0.0062	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000898	0.00608	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000883	0.00598	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000877	0.00594	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000869	0.00589	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000861	0.00583	CbGpPWpGaD
Alprazolam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000848	0.00814	CbGeAlD
Alprazolam—GABRA5—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000844	0.00572	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000839	0.00568	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000829	0.00562	CbGpPWpGaD
Alprazolam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000816	0.00784	CbGeAlD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000816	0.00553	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000815	0.00552	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000815	0.00552	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000809	0.00548	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0008	0.00542	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000795	0.00538	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000787	0.00533	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000782	0.00529	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000767	0.0052	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000767	0.0052	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000753	0.0051	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000752	0.00509	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000746	0.00505	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000732	0.00496	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000721	0.00489	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000719	0.00487	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000715	0.00484	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000713	0.00483	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000713	0.00483	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000711	0.00481	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000702	0.00476	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000701	0.00475	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000696	0.00471	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000696	0.00471	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000696	0.00471	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000695	0.00471	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000693	0.0047	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000693	0.0047	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000688	0.00466	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000681	0.00461	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000681	0.00461	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000676	0.00458	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000672	0.00455	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000671	0.00454	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000669	0.00453	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000669	0.00453	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000666	0.00451	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000665	0.0045	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000665	0.0045	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00066	0.00447	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000653	0.00442	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000653	0.00442	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000647	0.00438	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000643	0.00436	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000636	0.00431	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000635	0.0043	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000625	0.00423	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000624	0.00423	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00062	0.0042	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000618	0.00419	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000614	0.00416	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000613	0.00416	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000609	0.00412	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000607	0.00411	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000603	0.00408	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000599	0.00406	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000596	0.00404	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000594	0.00402	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000592	0.00401	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000588	0.00398	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000588	0.00398	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000582	0.00394	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000577	0.00391	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000571	0.00387	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00057	0.00386	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00057	0.00386	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000561	0.0038	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000551	0.00373	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000548	0.00371	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000547	0.0037	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000547	0.0037	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000538	0.00364	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000536	0.00363	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000532	0.00361	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000531	0.0036	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000531	0.0036	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000521	0.00353	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000521	0.00353	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000521	0.00353	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000514	0.00348	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000514	0.00348	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000513	0.00347	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000513	0.00347	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000512	0.00347	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000509	0.00345	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000509	0.00345	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000508	0.00344	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000503	0.00341	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0005	0.00339	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0005	0.00339	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0005	0.00338	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000491	0.00332	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000487	0.0033	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000473	0.00321	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00047	0.00318	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000465	0.00315	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000457	0.00309	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000454	0.00307	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000447	0.00303	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000446	0.00302	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000437	0.00296	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000437	0.00296	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000429	0.00291	CbGpPWpGaD
Alprazolam—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.0004	0.00271	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00039	0.00264	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000362	0.00245	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00036	0.00244	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000346	0.00234	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000336	0.00228	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00033	0.00223	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000324	0.0022	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000322	0.00218	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000318	0.00215	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000316	0.00214	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000314	0.00213	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000294	0.00199	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000294	0.00199	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000286	0.00193	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000286	0.00193	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00028	0.0019	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00028	0.0019	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000279	0.00189	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000276	0.00187	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000276	0.00187	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000276	0.00187	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000274	0.00185	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000274	0.00185	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000269	0.00182	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000269	0.00182	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000262	0.00177	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000255	0.00173	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000254	0.00172	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00025	0.00169	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000246	0.00166	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000244	0.00165	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000244	0.00165	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000244	0.00165	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00024	0.00162	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000239	0.00162	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000237	0.00161	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000235	0.00159	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000235	0.00159	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00023	0.00156	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000227	0.00154	CbGpPWpGaD
Alprazolam—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000226	0.00153	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000223	0.00151	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000223	0.00151	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000223	0.00151	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000209	0.00142	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000207	0.0014	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000195	0.00132	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00018	0.00122	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000176	0.00119	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000176	0.00119	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000176	0.00119	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000162	0.0011	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000161	0.00109	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00016	0.00108	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000153	0.00104	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000153	0.00103	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00015	0.00101	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000141	0.000954	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000134	0.000905	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000127	0.000863	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000124	0.000841	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000124	0.000841	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000123	0.000835	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000116	0.000784	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000114	0.000769	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000107	0.000724	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000106	0.000715	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000105	0.000714	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000101	0.000686	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	9.93e-05	0.000673	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	9.65e-05	0.000654	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	8.98e-05	0.000608	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	8.91e-05	0.000603	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	8.19e-05	0.000555	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	8.19e-05	0.000555	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	7.49e-05	0.000507	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	7.31e-05	0.000496	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.96e-05	0.000472	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	6.8e-05	0.000461	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	6.55e-05	0.000444	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	6.28e-05	0.000425	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.92e-05	0.000401	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.72e-05	0.000387	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.44e-05	0.000368	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	5.16e-05	0.000349	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5e-05	0.000339	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.71e-05	0.000319	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.49e-05	0.000304	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.14e-05	0.000281	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	4.11e-05	0.000279	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.93e-05	0.000266	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.61e-05	0.000245	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.4e-05	0.00023	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.22e-05	0.000218	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	2.97e-05	0.000201	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.82e-05	0.000191	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.77e-05	0.000188	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.55e-05	0.000173	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.1e-05	0.000142	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.04e-05	0.000138	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.83e-05	0.000124	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.68e-05	0.000114	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.44e-05	9.73e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.38e-05	9.36e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.47e-06	6.42e-05	CbGpPWpGaD
